October Pharma S.A.E (EGX:OCPH)

October Pharma S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	68.51	52.52	45.3	6.92	16.72	1.86
Cash & Short-Term Investments	68.51	52.52	45.3	6.92	16.72	1.86
Cash Growth	43.68%	15.96%	554.89%	-58.64%	798.79%	-89.19%
Accounts Receivable	205.84	229.21	209.3	144.45	97.04	84.73
Other Receivables	0.34	0.52	0.24	0.27	0.41	0.34
Receivables	494.98	602.65	579.83	364.81	118.84	214.67
Inventory	433.03	320.67	167.62	252.86	167.84	140.73
Prepaid Expenses	6.65	6.34	4.52	1.59	0.89	0.64
Other Current Assets	29.32	73.86	33.24	29.45	26.56	27.68
Total Current Assets	1,032	1,056	830.51	655.63	330.86	385.59
Property, Plant & Equipment	236.7	249.49	216.84	196.27	115.76	107.8
Other Intangible Assets	75.99	81.01	90.74	98.18	105.4	112.76
Long-Term Deferred Tax Assets	39.43	27.3	-	-	-	-
Other Long-Term Assets	-	-	-	-	1.03	-
Total Assets	1,385	1,414	1,138	950.08	553.06	606.15

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	54.47	76.42	82.27	92.51	35.37	26.22
Accrued Expenses	24.06	27.16	16.95	22.99	23.76	26
Short-Term Debt	333.7	456.58	216.99	203.34	15.25	165.64
Current Portion of Long-Term Debt	58.37	37.99	38.15	41.36	18.16	24.38
Current Portion of Leases	-	-	0.26	0.42	0.37	-
Current Income Taxes Payable	49.36	57.43	61.55	41.29	37.37	22.7
Other Current Liabilities	68.67	76.58	40.99	22.66	21.91	15.48
Total Current Liabilities	588.63	732.16	457.17	424.56	152.19	280.43
Long-Term Debt	33	57.76	68.57	77.42	39.69	58.3
Long-Term Leases	-	-	-	0.26	0.68	-
Pension & Post-Retirement Benefits	99.17	54.58	10.03	10.54	10.71	10.71
Long-Term Deferred Tax Liabilities	-	-	12.78	11.78	10.33	2.85
Total Liabilities	720.8	844.49	548.55	524.55	213.6	352.29

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	120	120	120	120	60	60
Retained Earnings	543.82	449.35	469.54	305.52	279.46	193.86
Shareholders' Equity	663.82	569.35	589.54	425.52	339.46	253.86
Total Liabilities & Equity	1,385	1,414	1,138	950.08	553.06	606.15

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	425.07	552.32	323.98	322.79	74.15	248.32
Net Cash (Debt)	-356.56	-499.8	-278.68	-315.87	-57.43	-246.46
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-29.71	-41.65	-23.22	-26.32	-4.79	-20.54
Filing Date Shares Outstanding	12	12	12	12	12	12
Total Common Shares Outstanding	12	12	12	12	12	12
Working Capital	443.87	323.88	373.34	231.07	178.67	105.16
Book Value Per Share	55.32	47.45	49.13	35.46	28.29	21.16
Tangible Book Value	587.83	488.34	498.79	327.34	234.05	141.1
Tangible Book Value Per Share	48.99	40.70	41.57	27.28	19.50	11.76
Land	0.42	-	0.42	0.42	0.42	0.42
Buildings	54.28	-	36.19	36.12	35.78	35.72
Machinery	354.51	-	145.86	148.8	141.84	136.56
Construction In Progress	4.03	57.46	129.44	100.41	19	6.57

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error